Key facts
- It has raised $2.0M; the latest was Later Stage VC in Jan 2027.
- Notable investors include Tech Incubator Program for Startup, Korea Credit Guarantee Fund, IBK Venture Investment, GTO Investment, iAccel (Seongnam-si).
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for GeoVista
- ·The full record, as it builds
Funding rounds
No funding rounds for GeoVista are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GeoVista
Developer of pet therapeutics designed to address chronic and age-related diseases in animals. The company offers treatments for atopic dermatitis, osteoarthritis, and separation anxiety, enabling pet owners to treat their pets.
- Sector
- Healthcare
- HQ
- Yongin, South Korea
- Founded
- 2020
- Employees
- 5
- Website
- geovista.org/
- Ownership
- Privately Held (backing)
GeoVista doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GeoVista shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GeoVista in its N-PORT filings yet. We sweep new filings monthly.